Skip to main content
logo
Nectar Lifesciences Limited (NSE:NECLIFE)
India flag India · Delayed Price · Currency is INR
13.31
-0.09 (-0.67%)
Feb 16, 2026, 3:00 PM IST

Nectar Lifesciences Revenue

Nectar Lifesciences had revenue of 16.70B INR in the twelve months ending December 31, 2025, down -0.66% year-over-year. In the fiscal year ending March 31, 2025, Nectar Lifesciences had annual revenue of 16.70B, down -0.84%.

Revenue
16.70B
Revenue Growth
-0.66%
P/S Ratio
0.16
Revenue / Employee
9.35M
Employees
1,786
Market Cap
2.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202516.70B-142.05M-0.84%
Mar 31, 202416.85B1.61B10.56%
Mar 31, 202315.24B-1.45B-8.70%
Mar 31, 202216.69B1.26B8.13%
Mar 31, 202115.43B-8.23B-34.78%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ind-Swift Laboratories5.94B
Sigachi Industries4.85B
Jagsonpal Pharmaceuticals2.82B
Sakar Healthcare2.31B
Valiant Laboratories2.03B
Bafna Pharmaceuticals1.47B
Vaishali Pharma1.17B
Alpa Laboratories1.14B
Revenue Rankings

Nectar Lifesciences News

More News